Jump to Main Content
Dietary Supplementation of Genistein Alleviates Liver Inflammation and Fibrosis Mediated by a Methionine-Choline-Deficient Diet in db/db Mice
- Yoo, Na-young, Joen, Sookyoung, Nam, Yerim, Park, Youn-Jin, Won, Sae Bom, Kwon, Young Hye
- Journal of agricultural and food chemistry 2015 v.63 no.17 pp. 4305-4311
- body weight, dietary supplements, endoplasmic reticulum, fatty liver, fibrosis, gene expression regulation, genes, genistein, inflammation, lipid peroxidation, liver, liver cirrhosis, mice, models, noninsulin-dependent diabetes mellitus, oxidative stress
- Nonalcoholic fatty liver disease is a complex disorder which includes simple steatosis, steatohepatitis, fibrosis and ultimately cirrhosis. Previous studies have reported that genistein, a soy phytoestrogen, attenuates steatohepatitis induced in obese and type 2 diabetic models. Here we investigated the effect of dietary genistein supplementation (0.05%) on nonalcoholic steatohepatitis (NASH) development induced by a methionine-choline-deficient (MCD) diet in db/db mice. MCD-diet-fed mice exhibited a significantly lower body weight and a higher degree of steatohepatitis with increased oxidative stress, steatosis, inflammation, stellate cell activation, and mild fibrosis. Although genistein did not inhibit hepatic steatosis, we observed that oxidative stress, endoplasmic reticulum stress, and AMP-dependent kinase inactivation were alleviated by genistein. Genistein also down-regulated the augmented gene expressions associated with hepatic inflammation and fibrosis. Therefore, these results suggest that genistein may protect MCD-diet-mediated NASH development by suppressing lipid peroxidation, inflammation, and even liver fibrosis in db/db mice.